GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abiomed Inc (FRA:AIO) » Definitions » Price-to-Owner-Earnings

Abiomed (FRA:AIO) Price-to-Owner-Earnings : 79.60 (As of May. 12, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Abiomed Price-to-Owner-Earnings?

As of today (2024-05-12), Abiomed's share price is €357.40. Abiomed's Owner Earnings per Share (TTM) ended in Sep. 2022 was €4.49. It's Price-to-Owner-Earnings for today is 79.60.


The historical rank and industry rank for Abiomed's Price-to-Owner-Earnings or its related term are showing as below:

FRA:AIO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 26.09   Med: 91.82   Max: 201.19
Current: 79.51

During the past 13 years, the highest Price-to-Owner-Earnings of Abiomed was 201.19. The lowest was 26.09. And the median was 91.82.


FRA:AIO's Price-to-Owner-Earnings is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 32.685 vs FRA:AIO: 79.51

As of today (2024-05-12), Abiomed's share price is €357.40. Abiomed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was €5.54. Therefore, Abiomed's PE Ratio (TTM) for today is 64.48.

As of today (2024-05-12), Abiomed's share price is €357.40. Abiomed's EPS without NRI for the trailing twelve months (TTM) ended in was €5.54. Therefore, Abiomed's PE Ratio without NRI for today is 64.48.

During the past 13 years, Abiomed's highest PE Ratio without NRI was 615.50. The lowest was 22.49. And the median was 87.01.


Abiomed Price-to-Owner-Earnings Historical Data

The historical data trend for Abiomed's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abiomed Price-to-Owner-Earnings Chart

Abiomed Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.41 67.03 29.04 66.75 156.77

Abiomed Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136.78 155.17 156.77 59.32 51.22

Competitive Comparison of Abiomed's Price-to-Owner-Earnings

For the Medical Devices subindustry, Abiomed's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abiomed's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abiomed's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Abiomed's Price-to-Owner-Earnings falls into.



Abiomed Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Abiomed's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=357.40/4.49
=79.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abiomed  (FRA:AIO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Abiomed Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Abiomed's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Abiomed (FRA:AIO) Business Description

Traded in Other Exchanges
N/A
Address
22 Cherry Hill Drive, Danvers, MA, USA, 01923
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

Abiomed (FRA:AIO) Headlines

From GuruFocus